Dissecting the role of the ATF4 stress response in T cell-mediated inflammation
Dissecting the role of the ATF4 stress response in T cell-mediated inflammation
批准号:
9240576
负责人:
Binfeng Lu
金额:
$23.25万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-08 至 2019-02-28
关键词:
AcuteAdoptive TransferAntigen-Presenting CellsAntioxidantsAutoimmune DiseasesAutoimmune ResponsesAutomobile DrivingCD4 Positive T LymphocytesCell Differentiation processCell physiologyCellsChronicClinicalCultured CellsDataDefectEnvironmentEquilibriumExperimental Autoimmune EncephalomyelitisFumaratesGene Expression ProfileGenesGenetic TranscriptionGoalsITGAX geneImmuneImmune responseIn VitroInflammationInflammation MediatorsInflammatoryInterferon Type IIInterleukin-17Knockout MiceKnowledgeMediatingMethodsMolecularMolecular GeneticsMultiple SclerosisMusMyeloid CellsNeurodegenerative DisordersOxidation-ReductionOxidative StressPathogenesisPathologicPathologyPathway interactionsPlayProductionProteinsReactive Oxygen SpeciesRoleT-LymphocyteTestingTh1 CellsTherapeuticTransgenic MiceWild Type Mouseactivating transcription factor 4amino acid metabolismautoreactivitybZIP Domainbasebiological adaptation to stresscell mediated immune responsecytokinedesignexperimental studyin vivoinsightknockout genemonocyteneutrophilnovel therapeutic interventionpublic health relevanceresponsesuccesstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant) Reactive oxygen species (ROS) play a major role in the pathogenesis of chronic inflammatory and autoimmune diseases. It is well established that ROS modulate T cell-mediated immune responses. However, little is known about underlying molecular mechanisms of how ROS regulate T cell immune responses and how T cells adapt to high levels of ROS. Our goal is to elucidate the transcriptional network regulating T cell adaption
to oxidative stress. In preliminary studies, we found ROS were elevated to much greater levels in CD4+ T cells cultured in Th1 conditions when compared to those cultured in Th0 and Th17 conditions. In further gene profiling studies, we demonstrated that ROS induced the gene expression signature of activating transcription factor-4 (ATF4) in activated Th1 cells in vitro an MOG-specific T cell in vivo. ATF4 is a basic leucine-zipper (bZip) transcription factor, which regulates cellular redox state and amino acid metabolism. We demonstrated that experimental allergic encephalomyelitis (EAE) was exacerbated in ATF4 deficient mice compared with wild type (WT) mice. Consistent with clinical scores of EAE, the number of autoreactive Th1 cells was decreased whereas that of autoreactive Th17 cells was elevated in ATF4 deficient mice compared with WT mice. We further showed that in vitro ATF4 deficiency in T cells resulted in great reduction of IFN-γ production in Th1 cultures and modest reduction of IL-17 in Th17 cultures. In contrast, in vitro, ATF4 deficiency in antigen presenting cells (APC) resulted in no change in IFN-γ production in Th1 cultures but an increase in IL-17 in Th17 cultures. Based on these new findings, we hypothesize that ATF4 promotes Th1 and suppresses Th17 immune responses in pathological conditions involving the oxidative stress. To test this hypothesis, we propose the following specific aims: Specific Aim 1. Determine the T cell autonomous role of ATF4 in Th1/Th17 differentiation in vivo. Specific Aim 2. Determine the role of ATF4 within myeloid cells in T helper cell differentiation in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
-
批准号:10703824
-
项目类别:
-
资助金额:$24.42万
-
财政年份:2022
-
负责人:Binfeng Lu
-
依托单位:
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
-
批准号:10625415
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2022
-
负责人:Binfeng Lu
-
依托单位:
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
-
批准号:10431979
-
项目类别:
-
资助金额:$13.3万
-
财政年份:2021
-
负责人:Binfeng Lu
-
依托单位:
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity
-
批准号:8443458
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2013
-
负责人:Binfeng Lu
-
依托单位:
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity
-
批准号:8602513
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2013
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7330322
-
项目类别:
-
资助金额:$30.16万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7031286
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7545810
-
项目类别:
-
资助金额:$30.16万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7162073
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7746479
-
项目类别:
-
资助金额:$29.86万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:7216788
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:7055357
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:6766894
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:6879128
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:6614073
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
海外基金